Rank (Similarity) |
PMID (PMCID) |
|
---|---|---|
2 (4.0%) |
11321500 |
Malignant mixed mullerian tumor of the ovary: report of four cases. Melilli GA, Nappi L, Carriero C, Lapresa M, Loizzi V, Caradonna F, Quaranta M, Putignano G. Eur J Gynaecol Oncol. 2001;22(1):67-9. |
Neoplasm | ||
Combined Modality Therapy Females Homo sapiens Middle Aged Mixed Tumor, Mullerian | ||
2 (4.0%) |
11285039 |
Carcinosarcoma of ovary associated with previous radiotherapy. Wei LH, Huang CY, Cheng SP, Chen CA, Hsieh CY. Int J Gynecol Cancer. 2001;11(1):81-4. |
Hepatic failure | ||
Antineoplastic Combined Chemotherapy Protocols Carcinosarcoma Combined Modality Therapy Fatal Outcome Females Hepatitis B Homo sapiens Neoplasms, Radiation-Induced Uterine Cervical Neoplasm | ||
2 (4.0%) |
10820916 |
Malignant mixed mullerian tumors of the ovary. Wei CF, Hwang SH, Ho CM, Shih BY, Chien TY. Zhonghua Yi Xue Za Zhi (Taipei). 2000;63(4):344-8. |
Carcinoma | ||
DES S100A1 VIM | ||
Adult Females Homo sapiens Middle Aged Mixed Tumor, Mullerian | ||
2 (4.0%) |
10726444 |
[Chemotherapy in the treatment of ovarian carcinosarcoma]. Melilli GA, Di Vagno G, Cormio G, Greco P, Fontana A, Carriero C, Loverro G, Selvaggi L. Minerva Ginecol. 1999;51(11):445-8. |
Renal insufficiency | ||
Antineoplastic Agents, Alkylating Antineoplastic Agents, Phytogenic Antineoplastic Combined Chemotherapy Protocols Carcinosarcoma Females Homo sapiens Middle Aged Retrospective Studies | ||
2 (4.0%) |
10637076 |
Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin. Sonoda Y, Saigo PE, Federici MG, Boyd J. Gynecol Oncol. 2000;76(2):226-9. |
Breast carcinoma | ||
BRCA1 BRCA2 TP53 | ||
BRCA2 Protein Carcinosarcoma DNA Mutational Analysis Females Germ-Line Mutation Homo sapiens Neoplasm Proteins Tumor Suppressor Genes | ||
2 (4.0%) |
8281496 |
Malignant mixed mullerian tumor of the ovary: report of a case and review of the literature. Shy SW, Lee WH, Lee MS, Lee MC. Zhonghua Yi Xue Za Zhi (Taipei). 1993;51(6):468-73. |
Carcinoma | ||
Females Homo sapiens Immunohistochemistry Malignant Mixed Tumor Middle Aged Mixed Tumor, Mullerian | ||
2 (4.0%) |
3457508 |
Ascitic fluid cytology in a case of metastatic malignant mixed mesodermal tumor of the ovary. Silverman JF, Gardner J, Larkin EW, Finley JL, Norris HT. Acta Cytol. 1986;30(2):173-6. |
Ovarian neoplasm | ||
Ascitic Fluid Epithelium Females Homo sapiens Hysterectomy Omentum Ovariectomy Ovary | ||
2 (4.0%) |
2197242 |
Malignant mixed mullerian tumor of the ovary with prominent neuroectodermal differentiation (teratoid carcinosarcoma). Ehrmann RL, Weidner N, Welch WR, Gleiberman I. Int J Gynecol Pathol. 1990;9(3):272-82. |
Teratoma | ||
Carcinosarcoma Females Histocytochemistry Homo sapiens Immunoenzyme Techniques Middle Aged Ovary Teratoma |
Total: 0
HPO ID | Term | Frequency |
---|
Total: 9
HPO ID | Term | # of case reports |
---|---|---|
HP:0002664 | Neoplasm | 2 |
HP:0100242 | Sarcoma | 2 |
HP:0000023 | Inguinal hernia | 1 |
HP:0001824 | Weight loss | 1 |
HP:0002027 | Abdominal pain | 1 |
HP:0002315 | Headache | 1 |
HP:0002861 | Melanoma | 1 |
HP:0009792 | Teratoma | 1 |
HP:0030833 | Neck pain | 1 |
Total: 0
Gene Symbol | Gene Name | Entrez Gene ID |
---|